Quantitative serum tumor markers (CEA, CA19-9, and CA-125) are independently predictive of survival in patients with appendiceal adenocarcinoma

被引：0
|
作者：
Shen, J. P. Y-C. [1 ]
Yousef, A. [1 ]
Yousef, M. M. G. [1 ]
Zeineddine, M. [1 ]
Chowdhury, S. [1 ]
Knafl, M. [2 ]
Raghav, K. [1 ]
White, M. G. [3 ]
Alfaro-Munoz, K. [1 ]
Helmink, B. [4 ]
Fournier, K. F. [4 ]
Overman, M. J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Colon & Rectal Surg, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Surg Oncol, Houston, TX USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2914
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
190P
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [41] Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma
    Xu, Hua-Xiang
    Liu, Liang
    Xiang, Jin-Feng
    Wang, Wen-Quan
    Qi, Zi-Hao
    Wu, Chun-Tao
    Liu, Chen
    Long, Jiang
    Xu, Jin
    Ni, Quan-Xing
    Yu, Xian-Jun
    SURGERY, 2017, 161 (02) : 373 - 384
  • [42] TUMOR-MARKER ANTIGEN CA125 IN PANCREATIC-CANCER - A COMPARISON WITH CA19-9 AND CEA
    HAGLUND, C
    BRITISH JOURNAL OF CANCER, 1986, 54 (06) : 897 - 901
  • [43] Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer
    Yanfeng Gao
    Jinping Wang
    Yue Zhou
    Sen Sheng
    Steven Y. Qian
    Xiongwei Huo
    Scientific Reports, 8
  • [44] Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer
    Gao, Yanfeng
    Wang, Jinping
    Zhou, Yue
    Sheng, Sen
    Qian, Steven Y.
    Huo, Xiongwei
    SCIENTIFIC REPORTS, 2018, 8
  • [45] Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor
    Tamakoshi, K
    Kikkawa, F
    Shibata, K
    Tomoda, K
    Obata, NH
    Wakahara, F
    Tokuhashi, Y
    Ishikawa, H
    Kawai, M
    Tomoda, Y
    GYNECOLOGIC ONCOLOGY, 1996, 62 (01) : 67 - 72
  • [46] RAISED SERUM LEVELS OF CA-125 IN PATIENTS WITH ENDOMETRIAL ADENOCARCINOMA
    DUK, MJ
    AALDERS, JG
    KOOI, H
    FLEUREN, GJ
    DEBRUIJN, HWA
    TUMOUR BIOLOGY, 1985, 6 (04): : 418 - 418
  • [47] Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
    van Manen, Labrinus
    Groen, Jesse V.
    Putter, Hein
    Vahrmeijer, Alexander L.
    Swijnenburg, Rutger-Jan
    Bonsing, Bert A.
    Mieog, J. Sven D.
    BIOMARKERS, 2020, 25 (02) : 186 - 193
  • [48] Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
    Liang, Lei
    Fang, Jingyang
    Han, Xuedi
    Zhai, Xichao
    Song, Yan
    Lu, Yiyan
    Zhang, Qian
    Ma, Ruiqing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Role of Tumour Markers CEA and CA19-9 in Colorectal Cancer
    Sreedhar, Rashmi
    Jajoo, Suhas
    Yeola, Meenakshi
    Lamture, Yashwant
    Tote, Darshana
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2020, 9 (46): : 3483 - 3488
  • [50] The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer
    Gaughran, Gregory
    Aggarwal, Neha
    Shadbolt, Bruce
    Stuart-Harris, Robin
    BREAST CANCER MANAGEMENT, 2020, 9 (04)
12345